A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

NCT01310322 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Asthma

Interventions

DRUG: AZD5423
DRUG: AZD5423
DRUG: AZD5423
DRUG: AZD5423

Sponsor

AstraZeneca